Health Services Research
Latest posts by Health Services Research (see all)
- Does Increased Medication Use among Seniors Increase Risk of Hospitalization and Emergency… - Sep. 29, 2016
- Differences in Hospital Readmission Risk across All Payer Groups in South Carolina - Sep. 28, 2016
- Rethinking Autonomy: Relationships as a Source of Resilience in a Changing Healthcare System - Sep. 23, 2016
- Socioeconomic Differences in Use of Low-Value Cancer Screenings and Distributional Effects in… - Sep. 14, 2016
Background Assessing the real-world comparative effectiveness of common interventions is challenged by unmeasured confounding. Objective To determine whether the mortality benefit shown for drug-eluting stents (DES) over bare metal stents (BMS) in observational studies persists after controls for/tests for confounding. Data Sources/Study Setting Retrospective observational study involving 38,019 patients, 65 years or older admitted for an index percutaneous coronary intervention receiving DES or BMS in Pennsylvania in 2004–2005 followed up for death through 3 years. Study Design Analysis was at the patient level.